NCT00916942 - Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions

Postherpetic Neuralgia

Interventions

DRUG

capsaicin 8%

High concentration capsaicin 8% dermal patch applied for one hour

DRUG

Lidocaine (2.5%)/Prilocaine (2.5%) Cream

Pre-treatment for NGX-4010

Trial Locations (6)

Clinical Trials of America, Inc., Hickory

Drug Studies America, Marietta

Comprehensive NeuroScience, Inc., St. Petersburg

Anchor Research Center, Naples

A & A Pain Institute, St Louis

Lifetree Clinical Research, Salt Lake City